| Catalog Number |
03P85-50 |
| Medical Device Problem Code |
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
| Health Effect - Clinical Code |
No Information (3190)
|
| Date of Event |
09/08/2017
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Apoc incident # (b)(4).Apoc labeling was evaluated during the investigation as pertaining to the event.The investigation was completed on 11/08/2017.Retain product was tested and functioning according to specification.Return product is not available for investigation.Investigation: a review of the device history record (dhr) confirmed the cartridge lot met finished goods (fg) release criteria.Retained cartridge testing met the acceptance criteria outlined in appendix 1 of q04.01.003 rev.Ab (product complaint level 2 and level 3 investigation procedure).No deficiency has been determined for the lot.Assessment: there are not repeats on either the i-stat or the laboratory instrument. unknown if two different samples, unknown how the samples were collected.The reporter was unsure as to how samples were handled. it is unknown if there was any delay from the time of collection of the i-stat sample to the time of test. samples for lactate should be analyzed immediately on drawing as lactate increases by as much as 70% within 30 minutes at 25 ºc as a result of glycolysis.Results on both instruments would be considered elevated (above the normal range of 0.36 to 1.25 mmol/l) and would not alter the medical treatment which would include administration of fluids and oxygen.The complaint investigation concluded there was no product deficiency and that the i-stat cartridge lot is meeting specification. .
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2017, abbott point of care was contacted by a customer regarding i-stat cg4+ cartridges that yielded suspected discrepant lactate result on a patient.There was no patient information available at the time of this report.Return product is not available for investigation.(b)(6).At the time of the event there was no indication of a product malfunction based on the information provided and assessed by apoc, however this mdr is a retrospective filing in response to an observation from an fda inspection conducted may 8th to 12th, 2017 at abbott point of care (b)(4).
|
| |
|
Search Alerts/Recalls
|